- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02854111
Using of Ice Cream for Diagnosis of Diabetes Mellitus
October 3, 2016 updated by: Chutintorn Sriphrapradang, Ramathibodi Hospital
Using of Ice Cream for Diagnosis of Diabetes Mellitus and Impaired Glucose Tolerance
The overall global prevalence of type 2 diabetes mellitus (DM) is rising.
Based on the latest Thai National Health Examination Survey, an estimated 3.2 million people had DM, of whom one-third was undiagnosed.
The inexpensive oral glucose tolerance test (OGTT) is a more sensitive and reliable test of DM than fasting plasma glucose (FPG) or HbA1c, and is recommended for diagnosing DM and impaired glucose tolerance (IGT).
Although the OGTT provides useful diagnostic information, poor patient tolerance of glucose solutions is inevitable.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Regarding the diagnosis of DM, oral glucose tolerance test (OGTT) identifies about 2% more individuals than does fasting plasma glucose (FPG).
Hence OGTT is the method that has high sensitivity compared to other methods for diagnosis of IGT (impaired glucose tolerance) and diabetes.
However, standard OGTT with 75-g glucose has poor patient tolerance and might cause reactive hypoglycemia.
The alternatives for 75-g glucose would help for screening of DM with better tolerance.
There were previous studies investigated substitutes for oral glucose solution with cookies and muffin.
In the present study we hypothesized that an alternative food such as ice cream, a favorite dessert, can use for evaluation of the diagnosis of DM and IGT instead of standard 75-g glucose.
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10400
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy volunteer
- agree to participate by written informed consent
Exclusion Criteria:
- previous history of diabetes mellitus
- pregnant woman
- hospitalised patients
- underlying disease of liver and kidney disease
- who take any medications that interfere with plasma glucose levels such as steroid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: oral glucose tolerance test
75-g glucose A blood sample will be collected when the participants arrive.
This is a fasting blood glucose value.
Then the participants will be asked to drink a sweet liquid containing 75 g-glucose.
Blood samples will be collected at timed intervals of 1 and 2 hours after you drink the glucose.
This is a standard method for diagnosis of diabetes mellitus that called oral glucose tolerance test or OGTT.
|
The 75-g glucose is used for standard oral glucose tolerance test.
|
Experimental: ice cream
A blood sample will be collected when the participants arrive.
This is a fasting blood glucose value.
Then the participants will be asked to drink ice cream that contained carbohydrate 73.9 g.
Blood samples will be collected at timed intervals of 1 and 2 hours after you eat the ice cream.
|
The ice cream was made by nutritionists in Ramathibodi Hospital.
It consisted of cornstarch, milk, sucrose, milk powder, egg yolk, and banana which contained carbohydrate 73.9 g, fat 27.7 g, protein 18.9 g for a total of 620.9 kcal with a cost of 35 bahts.
The time for complete ingesting 75-g glucose and ice cream was 5 and 15 minutes, respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The correct diagnosis of diabetes mellitus
Time Frame: 2 hours
|
We calculate the percentage of wrong diagnosis of diabetes mellitus when using ice cream instead of 75-g glucose (gold standard test).
We also calculate sensitivity and specificity of ice cream test for diagnosis of diabetes mellitus.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The correct diagnosis of impaired glucose tolerance
Time Frame: 2 hours
|
We calculate the percentage of wrong diagnosis of impaired glucose tolerance using ice cream instead of 75-g glucose (gold standard test).
We also calculate sensitivity and specificity of ice cream test for diagnosis of impaired glucose tolerance.
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chutintorn Sriphrapradang, M.D., Ramathibodi Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
July 28, 2016
First Submitted That Met QC Criteria
August 2, 2016
First Posted (Estimate)
August 3, 2016
Study Record Updates
Last Update Posted (Estimate)
October 4, 2016
Last Update Submitted That Met QC Criteria
October 3, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-55-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Joslin Diabetes CenterCambridge Medical Technologies, LLCCompletedType 2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on 75 g-glucose
-
King Abdulaziz Medical CityCompletedGestational DiabetesSaudi Arabia
-
Université de SherbrookeCanadian Diabetes AssociationCompleted
-
Glostrup University Hospital, CopenhagenUnknown
-
Hospital Universitario Dr. Jose E. GonzalezCompletedLow Birth Weight | Oral Glucose Tolerance TestMexico
-
Medical College of WisconsinActive, not recruitingHyperglycemia | DiabetesUnited States
-
University of Alabama at BirminghamUniversity of North Carolina, Chapel HillRecruitingGestational DiabetesUnited States
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Recruiting
-
University Hospital, Basel, SwitzerlandCompletedEndocrine System DiseasesSwitzerland
-
QuatRx Pharmaceuticals CompanyCompleted
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitation